Prelude is still going ahead. MRM per their half year report on the job and are tendering for Prelude work. Extract from half year investor preso
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025